/MDXH
MDXH Stock - MDxHealth S.A.
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$3.15-0.32%
$0.01 (-0.32%) • Dec 19
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.51
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+376.2%upside
Target: $15.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDXH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.12 – $3.18
TARGET (TP)$15.00
STOP LOSS$2.90
RISK/REWARD1:47.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.38
52W High$5.33
52W Low$1.35
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $90.05M | $70.19M | $37.05M | $22.24M | $18.46M |
| Gross Profit | $55.14M | $43.93M | $19.22M | $10.56M | $8.04M |
| Gross Margin | 61.2% | 62.6% | 51.9% | 47.5% | 43.6% |
| Operating Income | $-24,722,000 | $-27,327,000 | $-37,900,000 | $-26,841,000 | $-27,123,000 |
| Net Income | $-38,069,000 | $-43,100,000 | $-44,044,000 | $-29,002,000 | $-28,662,000 |
| Net Margin | -42.3% | -61.4% | -118.9% | -130.4% | -155.3% |
| EPS | $-0.78 | $-1.66 | $-2.78 | $-2.38 | $-3.44 |
Company Overview
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
4
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
4 Bullish0 Neutral/Bearish
Price Targets
$10
Average Target
↑ 217.5% Upside
Now
$7
Low
$10
Average
$18
High
Based on 4 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 17th 2025 | Craig Hallum | Initiation | Buy | $8 |
| October 31st 2024 | Lake Street | Initiation | Buy | $7 |
| May 31st 2023 | TD Cowen | Initiation | Outperform | $7 |
| July 18th 2022 | Oppenheimer | Resumed | Outperform | $18 |
Earnings History & Surprises
MDXHBeat Rate
29%
Last 17 quarters
Avg Surprise
-57.3%
EPS vs Estimate
Beats / Misses
5/12
Last 12 quarters
Latest EPS
$-0.16
Q4 2025
EPS Surprise History
Q1 24
-254.5%
$-0.39vs$-0.11
Q1 24
-254.5%
$-0.39vs$-0.11
Q3 24
-19.2%
$-0.31vs$-0.26
Q3 24
-19.2%
$-0.31vs$-0.26
Q1 25
+33.3%
$-0.14vs$-0.21
Q1 25
+33.3%
$-0.14vs$-0.21
Q3 25
-15.4%
$-0.15vs$-0.13
Q4 25
-33.3%
$-0.16vs$-0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | $-0.13 | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.12 | $-0.16 | -33.3% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $-0.13 | $-0.15 | -15.4% | ✗ MISS |
Q1 2025 | Feb 26, 2025 | $-0.21 | $-0.14 | +33.3% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $-0.21 | $-0.14 | +33.3% | ✓ BEAT |
Q3 2024 | Aug 21, 2024 | $-0.26 | $-0.31 | -19.2% | ✗ MISS |
Q3 2024 | Aug 21, 2024 | $-0.26 | $-0.31 | -19.2% | ✗ MISS |
Q1 2024 | Mar 6, 2024 | $-0.11 | $-0.39 | -254.5% | ✗ MISS |
Q1 2024 | Mar 6, 2024 | $-0.11 | $-0.39 | -254.5% | ✗ MISS |
Q3 2023 | Aug 23, 2023 | $-0.32 | $-0.30 | +6.3% | ✓ BEAT |
Q3 2023 | Aug 23, 2023 | $-0.32 | $-0.30 | +6.3% | ✓ BEAT |
Q1 2023 | Mar 8, 2023 | $-0.75 | $-1.10 | -46.7% | ✗ MISS |
Q1 2023 | Mar 8, 2023 | $-0.75 | $-1.10 | -46.7% | ✗ MISS |
Q3 2022 | Aug 25, 2022 | $-0.55 | $-0.70 | -27.3% | ✗ MISS |
Q3 2022 | Aug 25, 2022 | $-0.55 | $-0.70 | -27.3% | ✗ MISS |
Q1 2022 | Mar 2, 2022 | $-0.47 | $-1.29 | -174.0% | ✗ MISS |
Q1 2022 | Mar 2, 2022 | $-0.47 | $-1.17 | -148.9% | ✗ MISS |
Q3 2021 | Aug 26, 2021 | $-1.30 | — | — | — |
Q2 2021 | Jun 30, 2021 | $-1.30 | $-1.12 | +13.7% | ✓ BEAT |
Q1 2021 | Mar 3, 2021 | $-1.50 | — | — | — |
Latest News
TD Cowen Maintains Buy on MDxHealth, Raises Price Target to $7
📈 PositiveBenzinga•Nov 13, 2025, 06:55 PM
Lake Street Maintains Buy on MDxHealth, Raises Price Target to $9
📈 PositiveBenzinga•Nov 13, 2025, 06:12 PM
BTIG Maintains Buy on MDxHealth, Raises Price Target to $7
📈 PositiveBenzinga•Nov 13, 2025, 10:12 AM
MDxHealth Affirms FY2025 Sales Guidance of $108.000M-$110.000M vs $109.883M Est
➖ NeutralBenzinga•Nov 12, 2025, 09:23 PM
MDxHealth Q3 EPS $(0.16) Misses $(0.11) Estimate, Sales $27.433M Miss $28.126M Estimate
📉 NegativeBenzinga•Nov 12, 2025, 09:02 PM
Watching MDxHealth; Hearing Zacks Under $10 Newsletter Mentions Stock As A Buy
📈 PositiveBenzinga•Oct 28, 2025, 03:15 PM
Frequently Asked Questions about MDXH
What is MDXH's current stock price?
MDxHealth S.A. (MDXH) is currently trading at $3.15 per share. The stock has moved -0.32% today.
What is the analyst price target for MDXH?
The average analyst price target for MDXH is $15.00, based on 1 analyst.
What sector is MDxHealth S.A. in?
MDxHealth S.A. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is MDXH's market cap?
MDxHealth S.A. has a market capitalization of $0.16 billion, making it a small-cap company.
Does MDXH pay dividends?
No, MDxHealth S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACRS
Aclaris Therapeutics, Inc.
$3.14
Mkt Cap: $0.3B
ASMB
Assembly Biosciences, Inc.
$35.26
Mkt Cap: $0.3B
IMRX
Immuneering Corporation
$5.65
Mkt Cap: $0.2B
NEO
NeoGenomics, Inc.
$11.83
Mkt Cap: $0.3B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SI
SHOULDER INNOVATIONS, INC.
$15.32
Mkt Cap: $0.3B
SNWV
SANUWAVE Health, Inc.
$32.25
Mkt Cap: $0.3B
STXS
Stereotaxis, Inc.
$2.34
Mkt Cap: $0.2B
XGN
Exagen Inc.
$6.43
Mkt Cap: $0.1B
ZURA
Zura Bio Limited
$4.27
Mkt Cap: $0.3B
Explore stocks similar to MDXH for comparison